Viewing Study NCT01159067


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
Study NCT ID: NCT01159067
Status: TERMINATED
Last Update Posted: 2019-06-18
First Post: 2010-07-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Iron Overload View
None Accelerated Phase Chronic Myelogenous Leukemia View
None Adult Acute Lymphoblastic Leukemia in Remission View
None Adult Acute Myeloid Leukemia in Remission View
None Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities View
None Adult Acute Myeloid Leukemia With Del(5q) View
None Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) View
None Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) View
None Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) View
None Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) View
None Atypical Chronic Myeloid Leukemia, BCR-ABL Negative View
None Blastic Phase Chronic Myelogenous Leukemia View
None Chronic Eosinophilic Leukemia View
None Chronic Myelomonocytic Leukemia View
None Chronic Neutrophilic Leukemia View
None Chronic Phase Chronic Myelogenous Leukemia View
None de Novo Myelodysplastic Syndromes View
None Disseminated Neuroblastoma View
None Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue View
None Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable View
None Nodal Marginal Zone B-cell Lymphoma View
None Noncontiguous Stage II Adult Burkitt Lymphoma View
None Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma View
None Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma View
None Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma View
None Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma View
None Noncontiguous Stage II Adult Lymphoblastic Lymphoma View
None Noncontiguous Stage II Grade 1 Follicular Lymphoma View
None Noncontiguous Stage II Grade 2 Follicular Lymphoma View
None Noncontiguous Stage II Grade 3 Follicular Lymphoma View
None Noncontiguous Stage II Mantle Cell Lymphoma View
None Noncontiguous Stage II Marginal Zone Lymphoma View
None Noncontiguous Stage II Small Lymphocytic Lymphoma View
None Poor Prognosis Metastatic Gestational Trophoblastic Tumor View
None Previously Treated Myelodysplastic Syndromes View
None Primary Myelofibrosis View
None Recurrent Adult Acute Lymphoblastic Leukemia View
None Recurrent Adult Acute Myeloid Leukemia View
None Recurrent Adult Burkitt Lymphoma View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Adult Diffuse Mixed Cell Lymphoma View
None Recurrent Adult Diffuse Small Cleaved Cell Lymphoma View
None Recurrent Adult Hodgkin Lymphoma View
None Recurrent Adult Immunoblastic Large Cell Lymphoma View
None Recurrent Adult Lymphoblastic Lymphoma View
None Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma View
None Recurrent Grade 1 Follicular Lymphoma View
None Recurrent Grade 2 Follicular Lymphoma View
None Recurrent Grade 3 Follicular Lymphoma View
None Recurrent Malignant Testicular Germ Cell Tumor View
None Recurrent Mantle Cell Lymphoma View
None Recurrent Marginal Zone Lymphoma View
None Recurrent Mycosis Fungoides/Sezary Syndrome View
None Recurrent Neuroblastoma View
None Recurrent Ovarian Epithelial Cancer View
None Recurrent Ovarian Germ Cell Tumor View
None Recurrent Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Refractory Hairy Cell Leukemia View
None Relapsing Chronic Myelogenous Leukemia View
None Secondary Acute Myeloid Leukemia View
None Secondary Myelodysplastic Syndromes View
None Splenic Marginal Zone Lymphoma View
None Stage I Multiple Myeloma View
None Stage II Multiple Myeloma View
None Stage II Ovarian Epithelial Cancer View
None Stage III Adult Burkitt Lymphoma View
None Stage III Adult Diffuse Large Cell Lymphoma View
None Stage III Adult Diffuse Mixed Cell Lymphoma View
None Stage III Adult Diffuse Small Cleaved Cell Lymphoma View
None Stage III Adult Hodgkin Lymphoma View
None Stage III Adult Immunoblastic Large Cell Lymphoma View
None Stage III Adult Lymphoblastic Lymphoma View
None Stage III Chronic Lymphocytic Leukemia View
None Stage III Grade 1 Follicular Lymphoma View
None Stage III Grade 2 Follicular Lymphoma View
None Stage III Grade 3 Follicular Lymphoma View
None Stage III Malignant Testicular Germ Cell Tumor View
None Stage III Mantle Cell Lymphoma View
None Stage III Marginal Zone Lymphoma View
None Stage III Multiple Myeloma View
None Stage III Ovarian Epithelial Cancer View
None Stage III Small Lymphocytic Lymphoma View
None Stage IIIA Breast Cancer View
None Stage IIIB Breast Cancer View
None Stage IIIC Breast Cancer View
None Stage IV Adult Burkitt Lymphoma View
None Stage IV Adult Diffuse Large Cell Lymphoma View
None Stage IV Adult Diffuse Mixed Cell Lymphoma View
None Stage IV Adult Diffuse Small Cleaved Cell Lymphoma View
None Stage IV Adult Hodgkin Lymphoma View
None Stage IV Adult Immunoblastic Large Cell Lymphoma View
None Stage IV Adult Lymphoblastic Lymphoma View
None Stage IV Breast Cancer View
None Stage IV Chronic Lymphocytic Leukemia View
None Stage IV Grade 1 Follicular Lymphoma View
None Stage IV Grade 2 Follicular Lymphoma View
None Stage IV Grade 3 Follicular Lymphoma View
None Stage IV Mantle Cell Lymphoma View
None Stage IV Marginal Zone Lymphoma View
None Stage IV Ovarian Epithelial Cancer View
None Stage IV Small Lymphocytic Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HSCT, iron overload, deferasirox, labile plasma iron View